Qualcomm insider files Form 144 to sell 3,333 shares via Goldman Sachs
Rhea-AI Filing Summary
Qualcomm (QCOM) Section 144 notice for proposed sale of securities. The filing reports an intended sale of 3,333 shares of common stock through Goldman Sachs & Co. LLC with an aggregate market value of $529,213.74, scheduled approximately 09/02/2025. The shares were acquired on 12/09/2024 as performance award compensation and payment was recorded as compensation on that date.
The filing also discloses three sales by the same person in the past three months: 3,333 shares sold on 08/04/2025 for $493,610.30, 3,333 shares on 07/02/2025 for $537,559.91, and 3,333 shares on 06/02/2025 for $486,965.30. The filer certifies they are not aware of any undisclosed material adverse information.
Positive
- Clear disclosure of broker, acquisition date, nature of acquisition (performance awards), and planned sale details
- Prior sales in the past three months are fully disclosed, supporting transparency and compliance with Rule 144
- Filer representation states no known undisclosed material adverse information, as required
Negative
- Insider selling activity across multiple months may be viewed negatively by some investors
- No 10b5-1 plan date is provided in the filing, so the sales may not be documented under an affirmative written trading plan
Insights
Insider disposing of recently awarded compensation in multiple monthly tranches; transaction size is modest relative to issuer.
The filer plans to sell 3,333 shares acquired as performance awards on 12/09/2024, with recent monthly sales of identical lot sizes in June, July and August 2025. The planned sale value ($529,213.74) indicates each tranche is roughly half a million dollars at current market prices. For shareholders, these routine Rule 144 filings document liquidity events by an insider but do not by themselves disclose company operational changes.
Filing follows Rule 144 mechanics and includes the required representation about material nonpublic information.
The notice identifies the broker (Goldman Sachs & Co. LLC), the acquisition date and nature (performance awards), and prior sales within three months, which supports compliance with disclosure requirements. The signature representation that the seller is unaware of undisclosed material adverse information is present, reducing procedural compliance risk, although the filing does not provide any plan adoption date under Rule 10b5-1.